Key result
Inhibition of arginase II with small interfering RNA in aged mice significantly improved endothelium-dependent vasorelaxation to acetylcholine (Emax 94.36% vs 72.87%, P<0.01) by restoring eNOS coupling.
Why the study?
Does inhibiting arginase II with siRNA improve endothelial function in aged mice?
Does inhibiting arginase II with siRNA improve endothelial function in aged mice?
Absolute Event Rate: 94.36% vs 72.87%
p-value: p=<0.01
Inhibiting arginase II restores endothelial function in aged mice by preventing eNOS uncoupling, highlighting it as a potential therapeutic target for age-dependent vascular diseases.
May support ArgII inhibition for age-related endothelial dysfunction; leaves open clinical translation from in vitro data.
The incidence of cardiovascular disease is predicted to increase as the population ages. There is accumulating evidence that arginase upregulation is associated with impaired endothelial function. Here, we demonstrate that arginase II (ArgII) is upregulated in aortic vessels of aged mice and contributes to decreased nitric oxide (NO) generation and increased reactive oxygen species (ROS) production via endothelial nitric oxide synthase (eNOS) uncoupling. Inhibiting ArgII with small interfering RNA technique restored eNOS coupling to that observed in young mice and increased NO generation and decreased ROS production. Furthermore, enhanced vasoconstrictor responses to U46619 and attenuated vasorelaxation responses to acetylcholine in aged vasculature were markedly improved following siRNA treatment against ArgII. These results might be associated with increased L-arginine bioavailability. Collectively, these results suggest that ArgII may be a valuable target in age-dependent vascular diseases.
No takes yet. Share an insight, caveat, or question.
Shin et al. (2012) studied Age-dependent endothelial dysfunction. Small interfering RNA to arginase II (siArgII) vs. Untreated aged mice was evaluated on Endothelium-dependent vasorelaxation (Emax) to acetylcholine (p=<0.01). Inhibition of arginase II with small interfering RNA in aged mice significantly improved endothelium-dependent vasorelaxation to acetylcholine (Emax 94.36% vs 72.87%, P<0.01) by restoring eNOS coupling.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: